314 related articles for article (PubMed ID: 12882406)
41. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
42. Aging clock: the watchmaker's masterpiece.
Ishikawa F
Cell Mol Life Sci; 2000 May; 57(5):698-704. PubMed ID: 10892336
[TBL] [Abstract][Full Text] [Related]
43. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
44. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C
J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082
[TBL] [Abstract][Full Text] [Related]
45. Alternative product of the p16/CKDN2A locus connects the Rb and p53 tumor suppressors.
James MC; Peters G
Prog Cell Cycle Res; 2000; 4():71-81. PubMed ID: 10740816
[TBL] [Abstract][Full Text] [Related]
46. p53-Dependent and -independent functions of the Arf tumor suppressor.
Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
[TBL] [Abstract][Full Text] [Related]
47. Regulatory Network of ARF in Cancer Development.
Ko A; Han SY; Song J
Mol Cells; 2018 May; 41(5):381-389. PubMed ID: 29665672
[TBL] [Abstract][Full Text] [Related]
48. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
49. Ink4a/Arf links senescence and aging.
Sharpless NE
Exp Gerontol; 2004; 39(11-12):1751-9. PubMed ID: 15582292
[TBL] [Abstract][Full Text] [Related]
50. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
Kanellou P; Zaravinos A; Zioga M; Spandidos DA
Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
[TBL] [Abstract][Full Text] [Related]
51. The INK4a/ARF locus and melanoma.
Sharpless E; Chin L
Oncogene; 2003 May; 22(20):3092-8. PubMed ID: 12789286
[TBL] [Abstract][Full Text] [Related]
52. The INK4a/ARF tumor suppressor: one gene--two products--two pathways.
Chin L; Pomerantz J; DePinho RA
Trends Biochem Sci; 1998 Aug; 23(8):291-6. PubMed ID: 9757829
[TBL] [Abstract][Full Text] [Related]
53. [Cyclin-dependent kinase 4 inhibitor a and tumor].
Gong Z; Fu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):219-21. PubMed ID: 11402455
[TBL] [Abstract][Full Text] [Related]
54. The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth.
Ivanchuk SM; Mondal S; Dirks PB; Rutka JT
J Neurooncol; 2001 Feb; 51(3):219-29. PubMed ID: 11407594
[TBL] [Abstract][Full Text] [Related]
55. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.
Arcellana-Panlilio MY; Egeler RM; Ujack E; Magliocco A; Stuart GC; Robbins SM; Coppes MJ
Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782
[TBL] [Abstract][Full Text] [Related]
56. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
57. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas.
Labuhn M; Jones G; Speel EJ; Maier D; Zweifel C; Gratzl O; Van Meir EG; Hegi ME; Merlo A
Oncogene; 2001 Mar; 20(9):1103-9. PubMed ID: 11314047
[TBL] [Abstract][Full Text] [Related]
58. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N
Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621
[TBL] [Abstract][Full Text] [Related]
59. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
[TBL] [Abstract][Full Text] [Related]
60. Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic keratinocytes.
Chaturvedi V; Cesnjaj M; Bacon P; Panella J; Choubey D; Diaz MO; Nickoloff BJ
Am J Pathol; 2003 Jan; 162(1):161-70. PubMed ID: 12507899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
